Spinal Singularity to Present at the MedTech Strategist Innovation Summit
MedTech Strategist Innovation Summit, Nov. 27-28, at the Hyatt Regency San Francisco Airport, Burlingame, CA
SAN CLEMENTE, Calif., November 8, 2018 (Newswire.com) - Spinal Singularity, a developer and marketer of innovative treatments for bladder management, today announced that Bill Colone, Chief Executive Officer, will present at the upcoming MedTech Strategist Innovation Summit: Burlingame, Nov. 27-28, at the Hyatt Regency San Francisco Airport. Mr. Colone will present on Wednesday, Nov. 28 from 8:35-8:45 a.m. and will host a breakout session from 9:05-9:25 a.m. in the Harbour A meeting room.
For more information about the conference, please visit:
About Spinal Singularity Inc.
Spinal Singularity is a seed stage, venture-backed, medical device company developing products to improve the lives of patients with Spinal Injury. The company has developed the Connected Catheter, the first fully internal, smart catheter system for adult males with Urinary Retention. One Connected Catheter may replace up to 200 disposable intermittent catheters.
Spinal Singularity recently commenced Clinical Studies for the Connected Catheter in the USA. For more information or to see if you may qualify for this study, please visit the Company's website at www.spinalsingularity.com or contact us at email@example.com.
The Connected Catheter is currently an INVESTIGATIONAL DEVICE ONLY and Limited by Federal (or United States) law to investigational use.
Bill Colone, CEO
105 Avendia de la Estrella #3
San Clemente, CA 92672
Source: Spinal Singularity